Evidence map›Paper›PMID 39523886›Full record

ArticleInternational journal of technology assessment in health care2024

The three-domain impact framework for characterizing impact of patient involvement in health technology assessment.

Veronica Lopez Gousset, Aline Silveira Silva, Anke-Peggy Holtorf, Ana Toledo-Chávarri, Ann Single

Abstract read
In one paragraph

Article in International journal of technology assessment in health care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Two decades of impact: lessons from the HTAi Patient and Citizen Involvement in HTA Interest Group.International journal of technology assessment in health care · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Veronica Lopez GoussetVLG Consulting, Paris, France.ORCID https://orcid.org/0009-0003-0285-5774
Aline Silveira SilvaResearch Group on Access to Medicines and Responsible Use (AMUR-UnB), University of Brasilia, Brasilia, Brazil.ORCID https://orcid.org/0000-0002-5571-9077
Anke-Peggy HoltorfHealth Outcomes Strategies, Basel, Switzerland.ORCID https://orcid.org/0000-0002-4638-5351
Ana Toledo-ChávarriCanary Islands Health Research Institute Foundation (FCIISC), El Rosario, Spain.ORCID https://orcid.org/0000-0003-2395-3907
Ann SinglePatient Voice Initiative, Sydney, Australia.ORCID https://orcid.org/0000-0001-6601-0349

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesEvaluating the impact of patient involvement in health technology assessments (HTA) may help improve practices and avoid ineffective activities. Evaluation, however, continues to be infrequent, inconsistent, and often only relates to process quantity or quality. The Patient and Citizen Involvement in HTA Interest Group (PCIG) within Health Technology Assessment International set out to contextualize this impact to support evaluation.

methodsGiven the lack of established methodology to measure impact, the team performed a qualitative analysis of first-hand accounts about perceived changes in HTA due to involvement of patient stakeholders. A questionnaire was developed, piloted, and rolled out to collect personal perspectives from stakeholders with relevant experience. The stories were analyzed in the aggregate to identify themes in the data.

resultsFrom January 2019 to September 2021, twenty-four responses were collected through PCIG's network. Responses (including one joint industry-HTA body submission) came from patient representatives (12), HTA bodies (11), and industry representatives (2) from North America (5), South America (3), Europe (13), and Asia Pacific (3). Based on themes commonly reported, a three-domain framework for evaluating impact is proposed: impact on basis of HTA result or recommendation, impact on HTA body, and impact on patient participants. The framework includes components under each domain to support reporting.

conclusionsUsing the Three-Domain Impact Framework may be useful in identifying, evaluating, and communicating the value of patient involvement in HTA. Enhancing and increasing reporting practices may improve transparency and facilitate process improvements for meaningful integration of patient stakeholders into HTA appraisals across jurisdictions.

Indexed as

Patient ParticipationTechnology Assessment, BiomedicalHumansStakeholder Participationhealth technology assessmentimpactpatient involvementqualitative evaluation

Identifiers

PMID39523886
PMCPMC11579675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.